Express News | Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of Vp-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

BreakingsOct 24 19:00

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

GlobeNewswireOct 24 19:00

Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ...

Yahoo FinanceOct 10 06:21

Verrica Pharmaceuticals Strives for Nasdaq Compliance

TipRanksOct 9 04:48

Express News | Verrica Pharmaceuticals Inc: As a Result of Craig Ballaron's Resignation, Co Temporarily Not in Compliance With Nasdaq Listing Requirements

BreakingsOct 9 04:19

Verrica Pharmaceuticals Is Maintained at Outperform by RBC Capital

Dow JonesOct 5 00:06 · Ratings